Migraine sufferers could receive a daily pill on the NHS which can slash in half the frequency of their crippling headaches.
NHS spending watchdog, the National Institute for Health and Care Excellence (NICE), will decide later this month whether to offer the drug, named atogepant, to patients who have failed to respond to other treatments.
Experts expect the pill, which costs about £8,000 a year per patient, to be approved after studies revealed that it is significantly more effective than